WOODCLIFF LAKE, N.J. — The president of Par Pharmaceutical's subsidiary announced his resignation on Monday.

John MacPhee, who served as president of Strativa and Par EVP, will leave the company, effective Jan. 31, to pursue other interests.

Patrick LePore, Par's president, chairman and CEO, will assume day-to-day oversight of Strativa on an interim basis.